CIN Newsroom — 2026-09-03

The daily audio brief for institutional cannabis investors. MSO earnings, distressed cannabis names, capital markets, and the numbers behind the news.

Method: Generated from the live CIN Newsroom tape at cin-newsroom.pplx.app. Freshness bucketing, mover selection, and issuer status are computed from the same tape that powers the CanIDeal terminal.

Cannabis Investor News is editorial. CanIDeal is the commodities terminal it reports from.

CIN Newsroom — 2026-09-02

The daily audio brief for institutional cannabis investors. MSO earnings, distressed cannabis names, capital markets, and the numbers behind the news.

Method: Generated from the live CIN Newsroom tape at cin-newsroom.pplx.app. Freshness bucketing, mover selection, and issuer status are computed from the same tape that powers the CanIDeal terminal.

Cannabis Investor News is editorial. CanIDeal is the commodities terminal it reports from.

CIN Newsroom — 2026-09-01

The daily audio brief for institutional cannabis investors. MSO earnings, distressed cannabis names, capital markets, and the numbers behind the news.

Method: Generated from the live CIN Newsroom tape at cin-newsroom.pplx.app. Freshness bucketing, mover selection, and issuer status are computed from the same tape that powers the CanIDeal terminal.

Cannabis Investor News is editorial. CanIDeal is the commodities terminal it reports from.

CIN Newsroom — 2026-08-28

The daily audio brief for institutional cannabis investors. MSO earnings, distressed cannabis names, capital markets, and the numbers behind the news.

Method: Generated from the live CIN Newsroom tape at cin-newsroom.pplx.app. Freshness bucketing, mover selection, and issuer status are computed from the same tape that powers the CanIDeal terminal.

Cannabis Investor News is editorial. CanIDeal is the commodities terminal it reports from.

The single biggest question hanging over cannabis equities as the new week begins: will expanding breadth hold while macro volatility stays muted, allowing momentum names to extend gains into the week of Aug. 24–28, 2026?

Read the full US brief for 2026-08-23.

The single biggest question heading into the week: will the DEA rescheduling process—post-hearing briefs due August 17—produce enough regulatory clarity to move cannabis equities out of their current rangebound pattern?

Read the full US brief for 2026-08-16.

What’s the market pricing for a regulatory win — or a regulatory delay — after the DEA rescheduling hearing wraps up this week?

Read the full US brief for 2026-08-16.

The single biggest question heading into the week: will the DEA post-hearing schedule around August 17 trigger durable flows into U.S.-facing names, or will macro and narrow breadth keep cannabis equities rangebound?

Read the full US brief for 2026-08-16.

The single biggest question hanging over cannabis equities this week is whether the DEA rescheduling record will produce a concrete policy signal by way of post‑hearing filings and industry reaction, or whether markets will remain rangebound into late summer.

Read the full US brief for 2026-08-16.

The single biggest question heading into the week is whether the DEA rescheduling record will meaningfully shift capital flows into U.S.-exposed names ahead of post-hearing briefs due Monday, August 17.

Read the full US brief for 2026-08-16.